---
audienceLevel: patient
cancerTypes:
- breast
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Elacestrant Dihydrochloride - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/elacestrant-dihydrochloride
version: v1
---

# Elacestrant Dihydrochloride - NCI

# Elacestrant Dihydrochloride

Placeholder slot

(EH-lah-SES-trant dy-HY-droh-KLOR-ide)

Elacestrant dihydrochloride is a type of hormone therapy called a selective estrogen receptor degrader (or SERD). It binds to the estrogen receptor, causing it to be destroyed. This stops the growth of cancers that need estrogen to grow.

US Brand Name(s)

Orserdu

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa66ae5c-2bd2-4444-8178-b55651e054ef&audience=consumer)

## Use in Cancer

Elacestrant dihydrochloride
is approved to treat:

- **[Breast cancer](/Common/PopUps/popDefinition.aspx?id=444971&version=Patient&language=English)** that is [estrogen receptor (ER) positive](/Common/PopUps/popDefinition.aspx?id=45270&version=Patient&language=English) and [HER2 negative](/Common/PopUps/popDefinition.aspx?id=774531&version=Patient&language=English), has a [mutation](/Common/PopUps/popDefinition.aspx?id=46063&version=Patient&language=English) (change) in the *[ESR1](/Common/PopUps/popDefinition.aspx?id=811830&version=Patient&language=English)* gene, and has spread. It is used in [postmenopausal](/Common/PopUps/popDefinition.aspx?id=45269&version=Patient&language=English) women and in men whose cancer has gotten worse after at least one type of [hormone therapy](/Common/PopUps/popDefinition.aspx?id=45110&version=Patient&language=English).

Elacestrant dihydrochloride
is also being studied in the treatment of other types of
cancer.

## More About Elacestrant Dihydrochloride

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/768338) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Elacestrant Dihydrochloride](https://medlineplus.gov/druginfo/meds/a623011.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Hormone Therapy for Breast Cancer](https://www.cancer.gov/types/breast/breast-hormone-therapy-fact-sheet)

[Targeted Therapy to Treat Cancer](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Elacestrant Hydrochloride](https://www.cancer.gov/research/participate/clinical-trials/intervention/C171898) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
